GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » EBITDA Margin %

Qlife Holding AB (OSTO:QLIFE) EBITDA Margin % : -14,802.22% (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Qlife Holding AB's EBITDA for the three months ended in Sep. 2023 was kr-6.66 Mil. Qlife Holding AB's Revenue for the three months ended in Sep. 2023 was kr0.05 Mil. Therefore, Qlife Holding AB's EBITDA margin for the quarter that ended in Sep. 2023 was -14,802.22%.


Qlife Holding AB EBITDA Margin % Historical Data

The historical data trend for Qlife Holding AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB EBITDA Margin % Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
- -93.91 -88.67 -433.77

Qlife Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -754.96 -2,397.81 -9,408.94 -35,408.70 -14,802.22

Competitive Comparison of Qlife Holding AB's EBITDA Margin %

For the Medical Devices subindustry, Qlife Holding AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qlife Holding AB's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's EBITDA Margin % falls into.



Qlife Holding AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Qlife Holding AB's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-78.048/17.993
=-433.77 %

Qlife Holding AB's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-6.661/0.045
=-14,802.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qlife Holding AB  (OSTO:QLIFE) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Qlife Holding AB EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Qlife Holding AB (OSTO:QLIFE) Business Description

Traded in Other Exchanges
Address
Redaregatan 48, Helsingborg, SWE, SE-252 36
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines